Likes Subject
So we all know that Nasrat reads these jammy32 05/25/23 7:39 AM
Here’s the solid data on Elite’s awesome tech:
Bullish
Bullish
NASDAQ2020 02/06/23 9:28 PM
As is said...be careful of what one asks WeeZuhl 03/16/21 8:57 AM
Most won’t sell till buyout for max ROI
Bullish
Bullish
NASDAQ2020 06/04/23 7:28 PM
Up 30% from HammerBottom.
Bullish
Bullish
NASDAQ2020 06/04/23 7:21 PM
Nasrat is too busy, he's not going anywhere !!!!!
Bullish
Bullish
oliven 06/04/23 3:11 PM
Unless we file for a proxy that says jammy32 06/04/23 1:18 PM
That’s why I think we should sure the jammy32 06/04/23 12:42 PM
Nasrat controls the board and the company. He rdfdr1 06/04/23 12:40 PM
Yes. 1. Name ONE publicly-traded company on the aELmTPa 06/04/23 12:24 PM
Did some research on the safe harbor act. jammy32 06/04/23 12:07 PM
Do you agree that Nasrat should resign or jammy32 06/04/23 12:05 PM
The main motivator for investors seeking positive news namtae 06/04/23 12:00 PM
Won't do anything. aELmTPa 06/04/23 11:46 AM
Need some help like some NEWS truckdriver 06/04/23 11:44 AM
Serious question. Does any of what jammy32 06/04/23 11:18 AM
Seek help. aELmTPa 06/04/23 10:45 AM
So I read this line by line
Bullish
Bullish
sharkey1 06/04/23 10:24 AM
Elites CEO is the boss of all bosses. namtae 06/04/23 10:23 AM
I see Lannett still has Elite down as
Bullish
Bullish
sharkey1 06/04/23 9:46 AM
Looks like Mr. Kirkov needs a trip to Hawaii
Bullish
Bullish
sharkey1 06/04/23 9:36 AM
Sorry. What does carter ward have to jammy32 06/04/23 8:39 AM
Markets been going up. Unfortunately not jammy32 06/04/23 8:37 AM
Well, when people sell out of the blue
Bullish
Bullish
sharkey1 06/04/23 6:47 AM
Well technically not true. Elite’s stock jammy32 06/04/23 6:38 AM
Right on Jimmy Joe, I always said, park
Bullish
Bullish
sharkey1 06/04/23 6:29 AM
Do some research. It's for real. 9 month
Bullish
Bullish
Jimmy Joe 06/04/23 5:27 AM
Carter Ward locked $ loaded
Bullish
Bullish
NASDAQ2020 06/03/23 8:54 PM
I truly believe the best thing would be jammy32 06/03/23 4:37 PM
Doesn’t anyone find it odd that none of jammy32 06/03/23 3:28 PM
Does this hurt Elite ? Thanks jammy32 06/03/23 3:09 PM
Thanx sharks and all for your response bubba412 06/03/23 2:14 PM
Bubba, first thing, glad to see you can
Bullish
Bullish
sharkey1 06/03/23 2:04 PM
No more Purdue lost ALL of that in
Bullish
Bullish
NASDAQ2020 06/03/23 1:14 PM
Elite has a pathway forward for one
Bullish
Bullish
NASDAQ2020 06/03/23 1:12 PM
Lol such a joke. mrwrn2010 06/03/23 1:02 PM
What does this mean foe ELITE Anything? bubba412 06/03/23 12:50 PM
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171738205 aELmTPa 06/03/23 10:51 AM
2023 Purdue has been able to file new patents aELmTPa 06/03/23 10:49 AM
Purdue Patents for Extended-Release OxyContin Nixed in Intas Win
Bullish
Bullish
NASDAQ2020 06/03/23 10:46 AM
The one from Purdue may be a generic??
Bullish
Bullish
NASDAQ2020 06/03/23 10:41 AM
Bloomberg recently reported “Purdue Patents for Extended-Release OxyContin JamesF1 06/03/23 9:45 AM
Purdue has been able to file new patents jour_trader 06/03/23 9:24 AM
https://qz.com/1125690/big-pharma-is-taking-advantage-of-patent-law-to-keep-oxyc sharkey1 06/03/23 9:04 AM
https://www.drugs.com/availability/generic-oxycontin.html
Bullish
Bullish
sharkey1 06/03/23 8:38 AM
The trading range of 3-3.5 cents is on JamesF1 06/03/23 7:14 AM
The Accumulators.
Bullish
Bullish
NASDAQ2020 06/03/23 6:33 AM
Someone needs to pursue the trading patterns and jammy32 06/03/23 6:30 AM
https://www.cbsnews.com/news/purdue-pharma-opioids-settlements-sackler-family-pr
Bullish
Bullish
NASDAQ2020 06/02/23 9:11 PM
Can't rely on SEC to pursue this . rdfdr1 06/02/23 5:50 PM
Looking into it makes sense. It never JamesF1 06/02/23 4:13 PM
No selling shares are being held tightly.
Bullish
Bullish
NASDAQ2020 06/02/23 4:01 PM
I wonder why our CEO would continue to IB_ 06/02/23 2:49 PM
Likes Subject

jammy32
05/25/23 7:39 AM
WeeZuhl
03/16/21 8:57 AM
NASDAQ2020
06/04/23 7:28 PM
NASDAQ2020
06/04/23 7:21 PM
jammy32
06/04/23 1:18 PM
jammy32
06/04/23 12:42 PM
jammy32
06/04/23 12:07 PM
jammy32
06/04/23 12:05 PM
aELmTPa
06/04/23 11:46 AM
truckdriver
06/04/23 11:44 AM
jammy32
06/04/23 11:18 AM
aELmTPa
06/04/23 10:45 AM
sharkey1
06/04/23 10:24 AM
namtae
06/04/23 10:23 AM
sharkey1
06/04/23 9:46 AM
jammy32
06/04/23 8:39 AM
jammy32
06/04/23 8:37 AM
sharkey1
06/04/23 6:47 AM
sharkey1
06/04/23 6:29 AM
Jimmy Joe
06/04/23 5:27 AM
NASDAQ2020
06/03/23 8:54 PM
jammy32
06/03/23 4:37 PM
jammy32
06/03/23 3:09 PM
bubba412
06/03/23 2:14 PM
sharkey1
06/03/23 2:04 PM
NASDAQ2020
06/03/23 1:14 PM
NASDAQ2020
06/03/23 1:12 PM
mrwrn2010
06/03/23 1:02 PM
bubba412
06/03/23 12:50 PM
NASDAQ2020
06/03/23 10:41 AM
jour_trader
06/03/23 9:24 AM
JamesF1
06/03/23 7:14 AM
NASDAQ2020
06/03/23 6:33 AM
rdfdr1
06/02/23 5:50 PM
JamesF1
06/02/23 4:13 PM
NASDAQ2020
06/02/23 4:01 PM

Elite Pharmaceuticals Inc (ELTP)

Followers
915
Posters
Posts (Today)
24
Posts (Total)
380703
Created
03/24/09
Type
Free
Moderators mrwrn2010 aELmTPa NASDAQ2020 IB_ namtae



      Elite Pharmaceuticals, Inc
 

                       www.elitepharma.com                 

 
 
 
Products & Pipeline

 
Drug Market Size Status Competitors Marketed By
Adderall IR 335 M On Market 14 Elite
Adderall XR 1.56 B On Market 9 Elite
Dantrolene 6.3 M On Market 2 Elite
Isradipine 5.5 M On Market 1 Elite
Loxapine 5 M On Market 2 Elite
Phendimetrazine 4.5 M On Market 4 Elite
Trimipramine 2 M On Market 1 Elite
Naltrexone 16 M On Market 5 Tagi
Phentermine Capsules 7.5 M On Market 6 Tagi
Phentermine Tablets 40 M On Market 8 Tagi
Oxycodone IR 400 M On Market 10 Epic
Vigabatrin 275 M Approved - Launching
2nd half of 2023
15 Pyros
Doxycycline 85 M Approved - Evaluating
Market Opportunites
9 ----------
Tylenol with Codeine 45 M Approved - On Hold
(Opioid Product)
4 ----------
Undisclosed
Dopamine Agonist
12 M Filed with FDA
22 Dec 2022
---------- ----------
Undisclosed
Antimetabolite
42 M Filed with FDA
20 Apr 2023
---------- ----------
Generic OxyContin 517 M Human Insufflation
PK Study
---------- ----------
Generic Concerta 1.159 B In Development ---------- ----------
Generic Vyvanse 2.53 B In Development ---------- ----------
SequestOx 400 M On Hold ---------- ----------
 
 
 
Financials

 
Fiscal Year Revenue Change Net Income Change
2019 7,568,508   (9,279,321)  
2020 17,994,639 +137.76% (2,240,351) +75.86%
2021 25,380,749 +41.05% 5,088,421 +327.13%
2022 32,262,117 +27.11% 8,898,245 +74.87%
2023 29 June 2023   29 June 2023  
  


Board Manager:  aELmTPa
Last Updated:  
21 May 2023

 

New Post